Curia - About the company
Curia is an acquired company based in Albany (United States), founded in 1991 by Chet Opalka. It operates as a Provider of drug research & development, testing, and consulting services. Curia has raised an undisclosed amount in funding. The company has 373 active competitors, including 41 funded and 53 that have exited. Its top competitors include companies like Novartis, Catalent and Acclinate.
Company Details
- Website
- curiaglobal.com
- Registered Address
- Albany,New York
Key Metrics
Founded Year
1991
Location
Albany, United States
Stage
Acquired
Latest Funding Round
Investors
Ranked
4th among 373 active competitors
Employee Count
3,441 as on Sep 30, 2026
Investment & Acquisitions
Exit Details
Acquired by Aledade (Feb 21, 2023)
Legal entities associated with Curia
Curia is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CURIA GLOBAL, INC. CIN: 32067109739 , United States, Deadpooled | May 08, 2018 | - | - | - |
AMRI INDIA PRIVATE LIMITED CIN: U74999MH2007FTC169746 , India, Amalgamated | Apr 07, 2007 | ₹50 - ₹100 Cr (As on Mar 31, 2017) | - | |
CURIA INDIA PRIVATE LIMITED CIN: U73200TG2005PTC045178 , India, Active | Jan 25, 2005 | ₹100 - ₹500 Cr (As on Mar 31, 2025) | 545 (As on Aug 01, 2025) | |
Albany Molecular Research, Inc. CIN: 141742717 , United States, Active | Dec 31, 1999 | - | 1319 (As on Dec 31, 2024) | - |
Curia's acquisition details
Curia got acquired by Aledade on Feb 21, 2023.
Click here to take a look at Curia's acquisition in detail
Sign up to download Curia's company profile
Curia's funding and investors
Curia has raised funding over 2 rounds. Its first funding round was on Oct 14, 1999. Its latest funding round was a Grant (prize money) round on Apr 22, 2021 for $*****. 1 investor participated in its latest round. Curia has 8 institutional investors.
Here is the list of recent funding rounds of Curia:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Apr 22, 2021 | 2303127 | Grant (prize money) | 6401227 | 9249463 | 3733887 | 1824186 |
Oct 14, 1999 | 7960420 | Grant (prize money) | 1229248 | 5722013 | 1476030 |
View details of Curia's funding rounds and investors
Curia's founders and board of directors
Founder? Claim ProfileThe founders of Curia is Chet Opalka.
Here are the details of Curia's key team members:
- Chet Opalka: Co-founder / Retired of Curia.
View details of Curia's Founder profiles and Board Members
Curia's employee count trend
Curia has 3,441 employees as of Sep 26. Here is Curia's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Curia's Competitors and alternates
Top competitors of Curia include Novartis, Catalent and Acclinate. Here is the list of Top 10 competitors of Curia, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Novartis 1996, Basel (Switzerland), Acquired | R&D focused on manufacturing of drugs for multiple therapeutic areas | - | 71/100 | |
2nd | Catalent 2007, Somerset (United States), Acquired | Provider of development, manufacturing, and packaging solutions for medicines and supplements | - | 68/100 | |
3rd | Acclinate 2020, Birmingham (United States), Series A | Provider of clinical trial services to biopharma sector | $15.5M | 55/100 | |
4th | Curia 1991, Albany (United States), Acquired | Provider of drug research & development, testing, and consulting services | - | 53/100 | |
5th | WuXi Biologics 2008, Shanghai (China), Public | Developer and manufacturer for protein therapeutics | - | 52/100 | |
6th | Sunflower Therapeutics 2018, Hingham (United States), Series A | Provider of drug development & research services for multiple therapeutic areas | $5.64M | 52/100 | |
7th | ![]() Ventus Therapeutics 2019, Boston (United States), Series C | Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment | $300M | 51/100 | |
8th | BioFactura 2004, Frederick (United States), Series B | Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs | $7.8M | 51/100 | |
9th | Manufacturer of functional foods and dietary supplements | - | 49/100 | ||
10th | Organic synthesis, analytical, and peptide chemistry services for drug discovery and development | - | 49/100 |
Looking for more details on Curia's competitors? Click here to see the top ones
Curia's Investments and acquisitions
Curia has made 1 investments in companies including Fluorous Technologies. Curia has also acquired 11 companies including LakePharma and Integrity Bio.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 14, 2021 | Acquisition | 2009 | Belmont (United States) | |
Jul 13, 2021 | Acquisition | 2003 | Camarillo (United States) | |
May 05, 2016 | Acquisition | 1984 | Milano (Italy) |
See all acquisitions by Curia
Reports related to Curia
Here is the latest report on Curia's sector:
News related to Curia
Media has covered Curia for a total of 7 events in the last 1 year, 4 of them have been about company updates and 1 about partnerships.
•
Curia Invests $28 Million to Expand Sterile API Manufacturing in SpainAgencia EFE•Oct 05, 2026•Curia
•
eXoZymes Selects Curia as Commercial-Scale Manufacturing Partner for NCTNewswire•Sep 08, 2026•Exozymes, Curia
•
•
•
Switzerland's PolyPeptide Reviews Strategic Options After Takeover SpeculationMoneycab•Apr 14, 2026•PolyPeptide, EQT, Advent International, KKR and 6 others
•
•
•
Resilience Announces Appointment of William S. Marth, RPh., MBA as Chief Executive OfficerBusiness Wire•Dec 05, 2024•Resilience, Curia
•
Kindeva appoints CIO to lead digital transformation business initiativesEuropean Pharmaceutical Manufacturer•Nov 18, 2024•Kindeva Drug Delivery, Curia
•
Are you a Founder ?
FAQs about Curia
Explore our recently published companies
- Entrans - Prague based, 2003 founded, Funding Raised company
- Evolvez - New York based, 2019 founded, Unfunded company
- Kognico - New York based, 2003 founded, Unfunded company
- Happy Shark Media - New York based, 2019 founded, Unfunded company
- Spartan Institutional Research - New York based, 1996 founded, Unfunded company
- Ayoki Fabricon - Pune based, 1984 founded, Unfunded company

